We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MREO
10776
CALL
Mereo BioPharma
MREO
$50.9M
$166K ﹤0.01%
148,400
+132,600
+839% +$103K
TOKE
10777
DELISTED
Cambria Cannabis ETF
TOKE
$166K ﹤0.01%
+20,478
New +$196K
XTKG
10778
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
GRTS
10779
PUT
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$166K ﹤0.01%
68,700
-86,500
-56% -$227K
CD
10780
PUT
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$166K ﹤0.01%
+21,400
New +$138K
SRAX
10781
CALL
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$166K ﹤0.01%
50,000
-59,600
-54% -$220K
CATO icon
10782
CALL
Cato Corp
CATO
$67.9M
$165K ﹤0.01%
+14,200
New +$187K
CWK icon
10783
CALL
Cushman & Wakefield Ltd
CWK
$3.38B
$165K ﹤0.01%
+10,800
New +$190K
DOGZ icon
10784
Dogness International Corp
DOGZ
$16.8M
$165K ﹤0.01%
+4,541
New +$363K
OPRT icon
10785
PUT
Oportun Financial
OPRT
$355M
$165K ﹤0.01%
20,000
+9,500
+90% +$110K
IVC
10786
DELISTED
Invacare Corporation
IVC
$165K ﹤0.01%
128,707
+117,182
+1,017% +$154K
AIP icon
10787
Arteris
AIP
$1.39B
$164K ﹤0.01%
+23,470
New +$240K
CLNN icon
10788
Clene
CLNN
$52.9M
$164K ﹤0.01%
+3,263
New +$182K
BFX
10789
CALL
DELISTED
BowFlex Inc.
BFX
$164K ﹤0.01%
93,600
-5,500
-6% -$15.2K
ILLM
10790
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$164K ﹤0.01%
71,059
+38,456
+118% +$104K
EMWP
10791
DELISTED
Eros Media World PLC
EMWP
$164K ﹤0.01%
68,272
+57,178
+515% +$129K
POTX
10792
PUT
DELISTED
Global X Cannabis ETF
POTX
$164K ﹤0.01%
10,260
+1,410
+16% +$31.8K
ACRO.WS
10793
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$164K ﹤0.01%
819,599
-2,073
-0.3% -$692
CAPR icon
10794
Capricor Therapeutics
CAPR
$386M
$163K ﹤0.01%
46,852
-11,755
-20% -$41.7K
EVAX
10795
Evaxion A/S
EVAX
$27.9M
$163K ﹤0.01%
1,672
+1,417
+556% +$162K
GLBS icon
10796
CALL
Globus Maritime Ltd
GLBS
$78.6M
$163K ﹤0.01%
93,400
+28,700
+44% +$61.4K
IMMR icon
10797
PUT
Immersion
IMMR
$249M
$163K ﹤0.01%
30,500
-44,600
-59% -$231K
PLRX icon
10798
CALL
Pliant Therapeutics
PLRX
$66.3M
$163K ﹤0.01%
+20,300
New +$130K
PRDO icon
10799
CALL
Perdoceo Education
PRDO
$2B
$163K ﹤0.01%
13,800
-900
-6% -$9.86K
RSKD icon
10800
CALL
Riskified
RSKD
$875M
$163K ﹤0.01%
36,800
-31,400
-46% -$163K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.